Literature DB >> 13694492

Functional and metabolic properties of polymorphonuclear leucocytes. II. The influence of a lipopolysaccharide endotoxin.

Z A COHN, S I MORSE.   

Abstract

The effects of a purified bacterial lipopolysaccharide endotoxin on homogenous populations of rabbit polymorphonuclear leucocytes have been studied in vitro under defined conditions. Employing a 500-fold range of concentration (0.1 to 50.0 microg./ml.), it was shown that endotoxin enhanced the rate at which staphylococci were killed by leucocytes. The mechanism underlying the increased killing was found to be a direct stimulation of the phagocytic activity of the leucocyte and not mediated by the release of bactericidins or opsonins from the treated cells. In the presence of 10 per cent serum all concentrations of endotoxin enhanced phagocytosis, whereas at lower serum concentrations, the higher doses of lipopolysaccharide inhibited the phagocytic activity of the cells. Similar concentrations of endotoxin were capable of increasing the utilization of glucose and the production of lactic acid. Endotoxin treated leucocytes exhibited no change in oxygen consumption, and only a slight depression in glycogen synthesis. It appeared that endotoxin could interact and alter the functional and metabolic properties of leucocytes in the absence of serum. The demonstration of enhanced phagocytic activity of endotoxin-treated cells was dependent upon the particular opsonic requirements for the organism under study.

Entities:  

Keywords:  LEUKOCYTES; LIPOPOLYSACCHARIDES/pharmacology; PHAGOCYTOSIS; TOXINS AND ANTITOXINS/pharmacology

Mesh:

Substances:

Year:  1960        PMID: 13694492      PMCID: PMC2137280          DOI: 10.1084/jem.111.5.689

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Studies on the adjuvant action of bacterial endotoxins on antibody formation. I. Time limitation of enhancing effect and restoration of antibody formation in x-irradiated rabbits.

Authors:  P KIND; A G JOHNSON
Journal:  J Immunol       Date:  1959-05       Impact factor: 5.422

2.  The role of macrophages in the elimination of bacteria from the mouse peritoneum.

Authors:  J L WHITBY; D ROWLEY
Journal:  Br J Exp Pathol       Date:  1959-08

3.  Rapidly induced changes in the level of non-specific immunity in laboratory animals.

Authors:  D ROWLEY
Journal:  Br J Exp Pathol       Date:  1956-06

4.  [Effect of bacterial pyrogens (lipopolysaccharides) on phagocytic activity of granulocytes and on electric surface charging of the human blood cells in vivo].

Authors:  H BERGMANN; G BUSCHMANN; P DOERING; E FRITZE; F WENDT
Journal:  Klin Wochenschr       Date:  1954-06-01

5.  The properties and biologic effects of bacterial pyrogens.

Authors:  I L BENNETT; P B BEESON
Journal:  Medicine (Baltimore)       Date:  1950-12       Impact factor: 1.889

6.  The effect of bacterial constituents on the resistance of mice to heterologous infection and on the activity of their reticulo-endothelial system.

Authors:  D BOEHME; R J DUBOS
Journal:  J Exp Med       Date:  1958-04-01       Impact factor: 14.307

7.  The relationship between the vascular manifestations of shock produced by endotoxin, trauma, and hemorrhage. II. The possible role of the reticulo-endothelial system in resistance to each type of shock.

Authors:  B W ZWEIFACH; B BENACERRAF; L THOMAS
Journal:  J Exp Med       Date:  1957-09-01       Impact factor: 14.307

8.  Reversible changes in the susceptibility of mice to bacterial infections. I. Changes brought about by injection of pertussis vaccine or of bacterial endotoxins.

Authors:  R J DUBOS; R W SCHAEDLER
Journal:  J Exp Med       Date:  1956-07-01       Impact factor: 14.307

9.  Interactions between rabbit polymorphonuclear leucocytes and staphylococci.

Authors:  Z A COHN; S I MORSE
Journal:  J Exp Med       Date:  1959-09-01       Impact factor: 14.307

10.  Studies on the pathogenesis of fever. VI. The interaction of leucocytes and endotoxin in vitro.

Authors:  R D COLLINS; W B WOOD
Journal:  J Exp Med       Date:  1959-12-01       Impact factor: 14.307

View more
  62 in total

1.  Symposium on bacterial endotoxins. III. Metabolic effects of endotoxins on mammalian cells.

Authors:  M W WOODS; M LANDY; J L WHITBY; D BURK
Journal:  Bacteriol Rev       Date:  1961-12

2.  Symposium on bacterial endotoxins. II. Possible mechanisms whereby endotoxins evoke increased nonspecific resistance to infection.

Authors:  J L WHITBY; J G MICHAEL; M W WOODS; M LANDY
Journal:  Bacteriol Rev       Date:  1961-12

3.  In vitro effects of C-reactive protein on phagocytosis.

Authors:  Y HOKAMA; M K COLEMAN; R F RILEY
Journal:  J Bacteriol       Date:  1962-05       Impact factor: 3.490

Review 4.  Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis.

Authors:  Ira Tabas; Karin E Bornfeldt
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

5.  EFFECT OF MICROBIAL FRACTIONS ON THE METABOLISM OF LIVER AND MONOCYTES FROM MICE.

Authors:  R S Berk; E L Nelson
Journal:  J Bacteriol       Date:  1961-03       Impact factor: 3.490

6.  The Influence of Endotoxin on Resistance to Infection.

Authors:  A I Braude; J Siemienski
Journal:  Bull N Y Acad Med       Date:  1961-07

7.  Effect of endotoxin on cells and on their response to infection by polioviruses.

Authors:  W H MURPHY; C WISNER
Journal:  J Bacteriol       Date:  1962-03       Impact factor: 3.490

8.  Cerebrospinal fluid lactate in 78 cases of adult meningitis.

Authors:  B Genton; J P Berger
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

9.  Respiration and glucose oxidation in human and guinea pig leukocytes: comparative studies.

Authors:  R L Baehner; N Gilman; M L Karnovsky
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

10.  The dissociation by colchicine of phagocytosis from increased oxygen consumption in human leukocytes.

Authors:  S E Malawista; P T Bodel
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.